RELMADA THERAPEUTICS, INC. Operating Lease, Lease Income
RELMADA THERAPEUTICS, INC. (RLMD) reported Operating Lease, Lease Income of $4.90 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseLeaseIncome · last filed 2020-05-15
- RELMADA THERAPEUTICS, INC. operating lease, lease income for the quarter ending 2020-03-31 was $4.90K, a 22.22% decline year-over-year.
- RELMADA THERAPEUTICS, INC. operating lease, lease income for the quarter ending 2019-03-31 was $6.30K.
| Period end | Operating Lease, Lease Income 3 month |
|---|---|
| 2020-03-31 | $4.90K 10-Q · filed 2020-05-15 |
| 2019-03-31 | $6.30K 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |